Literature DB >> 25271118

Symptoms of attention-deficit hyperactivity disorder, nonsyndromic orofacial cleft children, and dopamine polymorphisms: a pilot study.

Emily E Hopkins1, Meredith L Wallace2, Yvette P Conley3, Mary L Marazita4.   

Abstract

PURPOSE: Attention-deficit hyperactivity disorder (ADHD) is a common childhood neurobehavioral disorder characterized by inattention, poor impulse control, and motor restlessness. Risk factors include familial stressors, anxiety disorders, learning disabilities, abnormal brain development, heritability, and dopamine polymorphisms. Children with an orofacial clefting (OFC) history are at increased risk of familial stressors, anxiety disorders, learning disabilities, and abnormal brain development. Given this overlap, we present a conceptual model proposing that children with OFC may be more likely to exhibit ADHD symptoms than children without and explore this relationship using pilot data.
DESIGN: This cross-sectional pilot study included 29 children with OFC or a first-degree relative with OFC recruited through a cleft research registry.
METHODS: The Disruptive Behavior Disorder Scale was used to collect data on children's ADHD symptoms. Saliva or whole blood samples were collected from children and parents for DNA analyses. ADHD-associated dopamine polymorphisms within the DRD4, DRD2, and DAT1 genes were genotyped. We tested for associations between presence of OFC and dopamine polymorphisms. Mixed-effects models tested whether children with OFC and dopamine polymorphisms had more ADHD symptoms.
RESULTS: The DRD4 4-repeat allele was associated with increased inattentive ADHD symptoms (p = .03). Having the DRD2 Taq1A1 allele and OFC predicted fewer (p = .02) inattentive ADHD symptoms. Children with OFC were significantly less likely to have the DAT1 10-repeat allele (p = .04).
CONCLUSIONS: Results indicate that further investigation among a larger sample of children with OFC is warranted, particularly for relationships with inattentive ADHD.
© The Author(s) 2014.

Entities:  

Keywords:  attention deficit hyperactivity disorder; dopamine polymorphism; nonsyndromic orofacial cleft

Mesh:

Substances:

Year:  2014        PMID: 25271118      PMCID: PMC4377310          DOI: 10.1177/1099800414552186

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  18 in total

1.  The role and interpretation of pilot studies in clinical research.

Authors:  Andrew C Leon; Lori L Davis; Helena C Kraemer
Journal:  J Psychiatr Res       Date:  2010-10-28       Impact factor: 4.791

2.  PCR detection of the TaqA RFLP at the DRD2 locus.

Authors:  D K Grandy; Y Zhang; O Civelli
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

3.  Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study.

Authors:  Karen Müller Smith; Mark Daly; Mariellen Fischer; Constantin T Yiannoutsos; Lorri Bauer; Russell Barkley; Bradford A Navia
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-05-15       Impact factor: 3.568

4.  Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.

Authors:  Mark A Bellgrove; Ziarah Hawi; Aiveen Kirley; Michael Gill; Ian H Robertson
Journal:  Neuropsychologia       Date:  2005       Impact factor: 3.139

5.  Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population.

Authors:  L Georgieva; A Dimitrova; I Nikolov; S Koleva; R Tsvetkova; M J Owen; D Toncheva; G Kirov
Journal:  Acta Psychiatr Scand       Date:  2002-05       Impact factor: 6.392

6.  Association of attention-deficit disorder and the dopamine transporter gene.

Authors:  E H Cook; M A Stein; M D Krasowski; N J Cox; D M Olkon; J E Kieffer; B L Leventhal
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

7.  Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity.

Authors:  I D Waldman; D C Rowe; A Abramowitz; S T Kozel; J H Mohr; S L Sherman; H H Cleveland; M L Sanders; J M Gard; C Stever
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

8.  Overdiagnosis and medication for attention-deficit hyperactivity disorder in children with cleft: diagnostic examination and follow-up.

Authors:  Lynn C Richman; Susan Ryan; Tammy Wilgenbusch; Tom Millard
Journal:  Cleft Palate Craniofac J       Date:  2004-07

Review 9.  The genetics of attention deficit hyperactivity disorder.

Authors:  Irwin D Waldman; Ian R Gizer
Journal:  Clin Psychol Rev       Date:  2006-02-28

10.  The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders.

Authors:  D E Comings; B G Comings; D Muhleman; G Dietz; B Shahbahrami; D Tast; E Knell; P Kocsis; R Baumgarten; B W Kovacs
Journal:  JAMA       Date:  1991-10-02       Impact factor: 56.272

View more
  3 in total

1.  Wavelet Screening identifies regions highly enriched for differentially methylated loci for orofacial clefts.

Authors:  William R P Denault; Julia Romanowska; Øystein A Haaland; Robert Lyle; Jack A Taylor; Zongli Xu; Rolv T Lie; Håkon K Gjessing; Astanand Jugessur
Journal:  NAR Genom Bioinform       Date:  2021-05-03

2.  The Relationship of Exposure to Anesthesia on Outcomes in Children With Isolated Oral Clefts.

Authors:  Amy L Conrad; Jon W Goodwin; James Choi; Robert I Block; Peg Nopoulos
Journal:  J Child Neurol       Date:  2016-12-20       Impact factor: 1.987

3.  Brain structure and neural activity related to reading in boys with isolated oral clefts.

Authors:  Amy Lynn Conrad; Emily Kuhlmann; Ellen van der Plas; Eric Axelson
Journal:  Child Neuropsychol       Date:  2021-02-09       Impact factor: 2.597

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.